AzTrials
AzTrials

Hospital DischargeNCT04547803

Post-discharge Early Assessment With a Video-visit

A study testing Video Visit in people with Hospital Discharge, run by Mayo Clinic at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine if a video visit with an advanced practice provider (Nurse Practitioner or Physician Assistant) within 7 days of discharge from Hospital Internal Medicine services will increase patient compliance with medication, self-management and home supports after hospital discharge. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Hospital Discharge
What is being tested?
Video Visit
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,190 participants
Where
1 siteUnited States
Study dates
10 Aug 2020to 1 Jul 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients aged ≥18 years
  • Patients discharged from a Hospital Internal Medicine service at Saint Marys Hospital
  • Patients or their legally authorized representative provides consent to participate in the study
  • Patients discharged home or to assisted living facility

Who cannot join

  • Patients discharged from Hospital Service Meds 1-4 and Med 17
  • Patient discharged with Care Transitions Program, or to Hospice, skilled nursing facility (SNF) or long-term acute care (LTAC) facility
  • Post-procedure patients (i.e., elective hospital admission for planned intervention or procedure)
  • Patient/legally authorized representative is Non-English speaking
  • Patient leaves the hospital Against Medical Advice (AMA)
  • No access to mobile technology/laptop/computer for post-discharge follow-up
  • Patient with an active diagnosis Covid-19 infection
  • Patients with a scheduled re-admission for a procedure, chemotherapy, or other treatment

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Mayo Clinic in Rochester

    Rochester, Minnesota, 55905

Other trials in United States

About this study

Official title: Post-discharge Early Assessment With Remote Video Link (PEARL) Initiative: A Randomized Controlled Trial

The purpose of this study is to determine if a video visit with an advanced practice provider (Nurse Practitioner or Physician Assistant) within 7 days of discharge from Hospital Internal Medicine services will increase patient compliance with medication, self-management and home supports after hospital discharge.

Read the detailed description

Prior to discharge, patients will be referred by Hospital Internal Medicine (HIM) teams to the PEARL team and screened for study eligibility. Eligible patients who provide oral consent to participate. Participants will be randomized 1:1 with comparisons between "Usual care" and "Usual care + Video-visit" arms. Participants randomized to the intervention arm will participate in a 15-20 minute Video visit (using Zoom®) with an advanced practice provider (APP; nurse practitioner or physician assistant in HIM) approximately 2-5 days after discharge. The telephone follow-up will occur 3-6 days after discharge. If a patient has a Video visit, the telephone follow-up will be scheduled for after the Video visit.

It is standard practice for HIM teams to make and coordinate outpatient appointments and activities including radiologic procedures for discharging patients. During this study, usual care will continue for patients in each arm. The intervention (Video-visit) is in addition to and not in place of the usual standard of care.

If issues/concerns beyond the scope of the video visit or telephone follow-up arise, then the PEARL APP will direct these to the discharging hospitalist team/supervising physician, or the participant's primary care provider (PCP) consistent with current standards of practice and management of post-discharge issues. Issues re-directed to the discharging hospitalist team or other providers will be documented in the Video-visit encounter. If the APP deems the clinical situation urgent or emergent, the APP will refer the patient to emergency services, or if needed ask the patient his/her location and contact 911. The APP will also immediately notify the study PI or co-PI who are both hospitalists and familiar with the practice. The APP will also notify the discharging hospitalist team.

Being tested
Standard of Care, Video Visit

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standard of CareOther

    Outpatient appointments and activities including radiologic procedures for discharging patients as standard of practice

  • Video VisitOther

    15-20 minute Video visit with an advanced practice provider (nurse practitioner or physician assistant) approximately 2-5 days after discharge.

Study groups in NCT04547803
Study groupRoleWhat they receive
Video Visit and Standard of CareExperimentalParticipants will participate in a video visit and standard of care
Receives: Other: Standard of Care; Other: Video Visit
Standard of CareActive comparatorParticipants will participate in standard of care for discharged patients.
Receives: Other: Standard of Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adherence to post-discharge recommendations

    Number of participants to adhere to post-discharge recommendation including medication compliance, self-management, and home supports post hospital discharge

    Measured: Through study completion, approximately 30 days

Secondary outcomes (2)
  1. 7 day readmission rate

    Number of participants with hospital emergency department visits and hospital readmission within 7 days of discharge

    Measured: 7 days after hospital discharge

  2. 30 day readmission rate

    Number of participants with hospital emergency department visits and hospital readmission within 30 days of discharge

    Measured: 30 days after hospital discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Sep 2020
  2. Study start10 Aug 2020
  3. Primary completion1 Jul 2022
  4. Study completion1 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,190 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04547803
Sponsor's protocol ID
20-004688
Status last verified
Aug 2022
First submitted
8 Sep 2020
Last updated
10 Aug 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Dugani SB, Kiliaki SA, Nielsen ML, Fischer KM, Lunde M, Kesselring GM, Lawson DK, Coons TJ, Schenzel HA, Parikh RS, Pagali SR, Liwonjo A, Croghan IT, Schroeder DR, Burton MC. Postdischarge Video Visits for Adherence to Hospital Discharge Recommendations: A Randomized Clinical Trial. Mayo Clin Proc Digit Health. 2023 Sep;1(3):368-378. doi: 10.1016/j.mcpdig.2023.06.006. Epub 2023 Aug 4.

    PubMed 37641718

Questions about this trial

What is this clinical trial studying?

A study testing Video Visit in people with Hospital Discharge, run by Mayo Clinic at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Adherence to post-discharge recommendations (time frame: Through study completion, approximately 30 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04547803, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Aug 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in